0 items USD 0.00Search
- Did you mean
- dystrophy (ald)
Your search for "leukodystrophy (ald)" gave back 2730 results.
Our latest Pharmaceutical and Healthcare disease pipeline guide Adrenoleukodystrophy - Pipeline Review, H1 2018, provides an overview of the...
颁补迟补濒辞驳:听
Global Markets Direct
May 2018
Price: USD 2,000.00
The global Metachromatic Leukodystrophy Treatment market size is predicted to grow from US$ 218 million in 2025 to US$ 274 million in 2031; it is...
颁补迟补濒辞驳:听
LPI
March 2025
Price: USD 3,660.00
The global Metachromatic Leukodystrophy (MLD) Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...
颁补迟补濒辞驳:听
MRRPB5
August 2024
Price: USD 2,900.00
The global market for Metachromatic Leukodystrophy Treatment was valued at US$ 216 million in the year 2024 and is projected to reach a revised size...
颁补迟补濒辞驳:听
MRRPB5
January 2025
Price: USD 2,900.00
Metachromatic leukodystrophy disease (MLD) is a deadly genetic condition caused by mutations in the ARSA gene that results in brain impairment and...
颁补迟补濒辞驳:听
MRRPB5
May 2024
Price: USD 2,900.00
Highlights The global Metachromatic Leukodystrophy (MLD) Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million...
颁补迟补濒辞驳:听
MRRPB5
March 2023
Price: USD 2,900.00
The global Globoid Cell Leukodystrophy Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing...
颁补迟补濒辞驳:听
MRRPB5
August 2024
Price: USD 2,900.00
Metachromatic leukodystrophy disease (MLD) is a deadly genetic condition caused by mutations in the ARSA gene that results in brain impairment and...
颁补迟补濒辞驳:听
MRRPB5
October 2023
Price: USD 2,900.00
Highlights The global Globoid Cell Leukodystrophy Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029...
颁补迟补濒辞驳:听
MRRPB5
March 2023
Price: USD 2,900.00
Metachromatic Leukodystrophy (MLD) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global...
颁补迟补濒辞驳:听
Global Markets Direct
November 2022
Price: USD 2,000.00
Metachromatic Leukodystrophy (MLD) (Central Nervous System) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical...
颁补迟补濒辞驳:听
Global Markets Direct
November 2021
Price: USD 2,000.00
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
颁补迟补濒辞驳:听
Global Markets Direct
December 2019
Price: USD 2,000.00
Globoid Cell Leukodystrophy (Krabbe Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary...
颁补迟补濒辞驳:听
Global Markets Direct
November 2022
Price: USD 2,000.00
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
颁补迟补濒辞驳:听
Global Markets Direct
June 2020
Price: USD 2,000.00
Metachromatic Leukodystrophy (MLD) - Pipeline Review, H1 2018 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease...
颁补迟补濒辞驳:听
Global Markets Direct
June 2018
Price: USD 2,000.00
听
